GlassScriptPhysician profile
Fadi Alhatem
NPI 1467672485
$2,721.36
in general payments reported to CMS, 2019-2025
17 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Pain Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $405).
See the full distribution for Pain Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $148 · 2021: $293 · 2022: $825 · 2023: $238 · 2024: $452 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863 · Travel and Lodging: $87.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.44 |
| Travel and Lodging | $87.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,159.16 | 2021-2025 | Intellis Adaptivestim |
| Saluda Medical Americas, INC. | $377.50 | 2024-2025 | Evoke |
| Nevro Corp. | $333.17 | 2021-2024 | Senza |
| Pfizer INC. | $171.60 | 2019 | |
| Amgen INC. | $168.16 | 2019 | |
| Abbott Laboratories | $119.88 | 2020-2021 | |
| Nalu Medical, INC. | $93.20 | 2023-2024 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $52.44 | 2019 | |
| Collegium Pharmaceutical, INC. | $46.67 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $44.53 | 2019-2023 | Ztlido |
| Medtronic USA, INC. | $38.53 | 2020 | |
| Boston Scientific Corporation | $26.78 | 2019 | |
| Biotronik Nro, INC. | $23.23 | 2023 | Biotronik |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.37 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $19.25 | 2023 | Seglentis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $14.26 | 2024 | Movantik |
| Biodelivery Sciences International, INC. | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fadi Alhatem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.